Irvine, CANCT06891898Now EnrollingIRB Ready

Type 1 Diabetes Clinical Trial in Irvine, CA

Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.

Sponsored by Beta Bionics, Inc.

Quick Self-Assessment

See if you qualify for this Irvine location

Preparing your pre-screening questions…

Expert Care in Irvine

Access type 1 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 1 diabetes treatment provided free

Apply for This Irvine Location

Check if you qualify for this type 1 diabetes clinical trial in Irvine, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Irvine

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Irvine site if eligible
  4. 4Begin participation

About This Type 1 Diabetes Study in Irvine

A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.

Sponsor: Beta Bionics, Inc.

Who Can Participate

Inclusion Criteria

Users must meet the following criteria in order to be enrolled in the study:
Diagnosed with type 1 diabetes and prescribed the iLet Bionic Pancreas System
At least 6 years of age
Using or planning to use either U100 Novolog (insulin aspart) or U100 Humalog (insulin lispro) in ready-to-fill cartridges, or U100 Fiasp® PumpCart® (insulin aspart) in pre-filled 1.6mL cartridges
Willing to provide HbA1c results obtained within the 6-month period prior to starting use of the iLet and during the last 6-months of study participation
Willing to provide CGM data, if available, obtained in the 1-month period prior to starting use of the iLet
For females, not pregnant or planning pregnancy in the next 12 months
Able to respond to alerts and alarms, and to provide basic diabetes self-management
Reside full-time in the US
Able to speak and read English
Willing and able to download the iLet Mobile App and keep it active throughout the study and upload device data regularly
Willing to answer baseline survey, monthly surveys, and share CGM data, and follow-up data, as necessary

Exclusion Criteria

Users with the following characteristics will not be considered candidates for the study:
Type 2 diabetes, cystic fibrosis-related diabetes, congenital hyperinsulinism, pancreatogenic diabetes, or any form of diabetes mellitus other than type 1 diabetes
Use or planned use of any insulin in the iLet other than U100 Novolog (insulin aspart) or U100 Humalog (insulin lispro) in ready-to-fill cartridges, or U100 Fiasp® PumpCart® (insulin aspart) in pre-filled 1.6mL cartridges
End-stage renal disease on renal replacement therapy (peritoneal dialysis or hemodialysis)
Use or planned use of hydroxyurea

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Irvine?

Yes, this clinical trial (NCT06891898) has an active research site in Irvine, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Treatment Options in Irvine, CA

If you're searching for type 1 diabetes treatment options in Irvine, CA, this clinical trial (NCT06891898) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Irvine, CA

See all pulmonary embolism clinical trials recruiting in Irvine — not just this study.

Browse Pulmonary Embolism Trials in Irvine →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 1 Diabetes TrialsJuvenile Diabetes TrialsAll Conditions →

Ready to Join in Irvine?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Irvine, CA